{"id":434175,"date":"2025-12-08T22:03:09","date_gmt":"2025-12-08T22:03:09","guid":{"rendered":"https:\/\/www.europesays.com\/us\/434175\/"},"modified":"2025-12-08T22:03:09","modified_gmt":"2025-12-08T22:03:09","slug":"fda-announces-class-iii-recall-for-ziac-blood-pressure-tablets","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/434175\/","title":{"rendered":"FDA announces Class III recall for Ziac blood pressure tablets"},"content":{"rendered":"<p class=\"article__paragraph article__paragraph--left\" id=\"COYI7JVRHFC5TMDR2QE2L3CJXY\">Over 11,000 bottles of a high blood pressure medication have been recalled for potential cross contamination with another drug.<\/p>\n<p class=\"article__paragraph article__paragraph--left\" id=\"3QIKLKHG7ZB37HWSJ4KYNMFFQM\">Glenmark Pharmaceuticals Inc., based in New Jersey, has voluntarily recalled thousands of units of bisoprolol fumarate and hydrochlorothiazide tablets (Ziac) for potentially containing amounts of a high cholesterol drug, according to <a href=\"https:\/\/www.newsnationnow.com\/us-news\/recalls\/high-blood-pressure-med-recall\/\" target=\"_blank\" rel=\"noopener\">NewsNation<\/a>. <\/p>\n<p class=\"article__paragraph article__paragraph--left\" id=\"2YZ27CRESJCBHPJFWOBTVUELNU\">The drugmaker tested reserve samples, which revealed the presence of ezetimibe, a drug used to treat high cholesterol. <\/p>\n<p class=\"article__paragraph article__paragraph--left\" id=\"42KNPWV3BVCWLIFGE5UR5M6GUU\">The Federal Drug Administration classified the recall with a <a href=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\" target=\"_blank\" rel=\"noopener\">Class III<\/a> risk level. This means the use or exposure to the recalled product \u201cis not likely to cause adverse health consequences,\u201d according to the FDA. <\/p>\n<p class=\"article__paragraph article__paragraph--left\" id=\"RPO44I6JORD4TIRGQMPXUWUL4E\">Affected tablets range from 2.5 mg to 6.25 mg dosages in different bottle sizes with expiration dates starting November 2025 through December 2026.<\/p>\n<p class=\"article__paragraph article__paragraph--left\" id=\"AIROX7OUJZF57DK7YQ7GBX3ABQ\">Consumers can identify affected lots by these lot codes:<\/p>\n<ul class=\"article__unordered-list\">\n<li id=\"JSEZCOGJJFGW3GGT3GOLI7PKTQ\">30-count bottles, NDC-68462-878-30<\/li>\n<li id=\"3ZVZIIK2HVF3VMHSONXADKFCJQ\">100-count bottle, NDC-68462-878-01<\/li>\n<li id=\"FTFCWJX4IBDF7JDV4UOF3A5OGA\">500-count bottle, NDC-68462-878-05<\/li>\n<\/ul>\n<p class=\"article__paragraph article__paragraph--left\" id=\"CHTMGLYFQZCHLOYMGSPHWY4WQQ\">Glenmark and the FDA have yet to issue recommendations on what to do with the recalled drug.<\/p>\n","protected":false},"excerpt":{"rendered":"Over 11,000 bottles of a high blood pressure medication have been recalled for potential cross contamination with another&hellip;\n","protected":false},"author":3,"featured_media":434176,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-434175","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115686211877097331","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/434175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=434175"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/434175\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/434176"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=434175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=434175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=434175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}